US 11,511,762

Application 16/682,644 · Granted Nov 29, 2022

Redundancy system and method

Estimated expiration

April 3, 2040

13y 137d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Nov 13, 2019
+ 20 years
Nov 13, 2039
PTA +142d
Apr 3, 2040
No TD
—
Final
Apr 3, 2040

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
November 13, 2019
Earliest effective filing
November 13, 2019
Issue date
November 29, 2022
PTA
+142 days
Base expiry (before PTA)
November 13, 2039

November 13, 2019 + 20 years = November 13, 2039 + 142 PTA days = April 3, 2040

  • PRO62/760,575 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 16/682,644 · US 11,511,762

PatentReply compiles the prosecution history behind US 11,511,762: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US11511762

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.